RALY promotes Epithelial-mesenchymal transition in Hepatocellular carcinoma by regulating Snail
Open Access
- 3 February 2026
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 805, 153402
Abstract
No abstract availableKeywords
Funding Information
- Korea Research Institute of Bioscience and Biotechnology
- Korea Ministry of Science and ICT (KGM9992413)
This publication has 20 references indexed in Scilit:
- SUMOylation of RALY promotes vasculogenic mimicry in glioma cells via the FOXD1/DKK1 pathwayCell Biology and Toxicology, 2023
- Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkersCancer and Metastasis Reviews, 2023
- RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinomaCancer Letters, 2022
- RALY may cause an aggressive biological behavior and a dismal prognosis in non-small-cell lung cancerExperimental Cell Research, 2020
- EMT Transition States during Tumor Progression and MetastasisTrends in Cell Biology, 2019
- RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cellsThe International Journal of Biochemistry & Cell Biology, 2017
- Role of epithelial to mesenchymal transition in hepatocellular carcinomaJournal of Hepatology, 2016
- EMT: 2016Cell, 2016
- Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial–mesenchymal transition in gastrointestinal cancerEuropean Journal of Cancer, 2013
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009